PLX - Protalix BioTherapeutics Inc.
2.12
-0.030 -1.415%
Share volume: 722,028
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$2.15
-0.03
-0.01%
Summary score
29%
Profitability
32%
Dept financing
25%
Liquidity
27%
Performance
26%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
19.74%
Return on assets
-8.56%
Return on sales
-141.94%
Return on invested capital
72.49%
Total debt ratio
173.14%
Debt ratio change over timeo
0%
Current Ratio
1.87%
Quick Ratio
1.59%
Cash Position Ratio
1.2%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
4.86%
Return on assets
0.87%
Return on sales
-2.79%
Return on invested capital
5.52%
Total debt ratio
171.68%
Debt ratio change over timeo
0%
Current Ratio
1.17%
Quick Ratio
0.93%
Cash Position Ratio
0.3%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
13.32%
Return on assets
-3.57%
Return on sales
-23.93%
Return on invested capital
13.9%
Total debt ratio
146.07%
Debt ratio change over time
0%
Current Ratio
1.37%
Quick Ratio
1.07%
Cash Position Ratio
0.31%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PLX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 19.74% | 12.3% | 4.66% | 8.41% |
| Return on assets | -8.56% | 3.6% | 3.82% | 5.9% |
| Return on sales | -141.94% | 41.82% | 38.61% | 44.98% |
| Return on invested capital | 72.49% | 7.81% | 4.85% | 8.03% |
| Profitability | 50% | 57% | 45% | 63% |
| Total debt ratio | 173.14% | 75.51% | 65.79% | 48.93% |
| Debt ratio change over time | 0% | 0% | 341.77% | 4.46% |
| Dept financing | 25% | 11% | 34% | 7% |
| Current Ratio | 1.17% | 1.87% | 2.93% | 1.99% |
| Quick Ratio | 0.93% | 1.53% | 2.83% | 1.77% |
| Cash Position Ratio | 0.3% | 0.73% | 2.29% | 0.99% |
| Liquididy | 40% | 57% | 71% | 44% |
| Short-term ratios | PLX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 4.86% | 18.05% | 0.63% | 10.52% |
| Return on assets | 0.87% | 3.58% | 3.44% | 6.39% |
| Return on sales | -2.79% | 36.22% | 35.02% | 46.53% |
| Return on invested capital | 5.52% | 5.97% | 1.16% | 9.33% |
| Profitability | 25% | 74% | 36% | 90% |
| Total debt ratio | 171.68% | 83.77% | 66.41% | 53.87% |
| Debt ratio change over time | 0% | 0% | -1.12% | 4.06% |
| Dept financing | 25% | 12% | 10% | 33% |
| Current Ratio | 1.17% | 1.87% | 2.93% | 1.99% |
| Quick Ratio | 0.93% | 1.53% | 2.83% | 1.77% |
| Cash Position Ratio | 0.3% | 0.73% | 2.29% | 0.99% |
| Liquididy | 21% | 37% | 75% | 43% |